1. Home
  2. CLAR vs KLRS Comparison

CLAR vs KLRS Comparison

Compare CLAR & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clarus Corporation

CLAR

Clarus Corporation

N/A

Current Price

$3.36

Market Cap

104.9M

ML Signal

N/A

Logo Kalaris Therapeutics Inc.

KLRS

Kalaris Therapeutics Inc.

N/A

Current Price

$2.85

Market Cap

92.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLAR
KLRS
Founded
1957
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.9M
92.8M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CLAR
KLRS
Price
$3.36
$2.85
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
$3.50
★ $18.71
AVG Volume (30 Days)
★ 91.7K
50.3K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
★ 2.95%
N/A
EPS Growth
11.68
★ 75.70
EPS
★ 0.04
N/A
Revenue
★ $228,000.00
$165,000.00
Revenue This Year
$0.10
N/A
Revenue Next Year
$3.32
N/A
P/E Ratio
$85.75
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.53
$2.81
52 Week High
$3.98
$11.88

Technical Indicators

Market Signals
Indicator
CLAR
KLRS
Relative Strength Index (RSI) 37.40 26.31
Support Level $3.29 N/A
Resistance Level $3.50 $4.37
Average True Range (ATR) 0.10 0.15
MACD -0.03 -0.02
Stochastic Oscillator 5.00 18.71

Price Performance

Historical Comparison
CLAR
KLRS

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and U.S.

About KLRS Kalaris Therapeutics Inc.

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

Share on Social Networks: